» Articles » PMID: 35906362

Quality of Life, Respiratory Symptoms, and Health Care Utilization 1 year Following Outpatient Management of COVID-19: a Prospective Cohort Study

Abstract

The long-term impact of COVID-19 among those with mild infections is not well characterized. Among 81 adults who completed online assessments at 3- and 12-months following infection, quality of life scores did not significantly improve over time. Among 62 subjects who also completed telephone interviews, respiratory symptoms or exercise limitation were reported by 42% at a median follow-up of 387 days (IQR 251-402 days). Those with persistent respiratory symptoms scored lower on the EQ-5D visual analog score compared to those without. Persistent respiratory symptoms were associated with a lower likelihood of full-time employment at 1 year (aOR 0.09, 95%CI 0.01-0.91; P = 0.041). In an adjusted linear regression, persistent respiratory symptoms (P = 0.037) and female sex (P = 0.016) were both independent risks for increased visits to a primary care provider. This cohort study demonstrates that respiratory symptoms are frequent at 1 year following COVID-19 and more importantly, are associated with negative impacts on employment, quality of life, and health care utilization. Further research is needed to determine the pathophysiology and risk factors for persistent symptoms as well as optimal management strategies to improve the level of functioning and quality of life.

Citing Articles

Health-Related Quality of Life One Year After Intensive Care Unit Admission for COVID-19: A Retrospective, Cross-Sectional, Longitudinal Observational Study.

Samuelsson C, Hussain N, Drummond A, Persson C Health Sci Rep. 2025; 8(2):e70507.

PMID: 40008224 PMC: 11850194. DOI: 10.1002/hsr2.70507.


Quality of Sleep and Mental Symptoms Contribute to Health-Related Quality of Life after COVID-19 Pneumonia, a Follow-Up Study of More than 2 Years.

Jauregui-Renaud K, Cooper-Bribiesca D, Miguel-Puga J, Alcantara-Calderon Y, Roaro-Figueroa M, Herrera-Ocampo M Biomedicines. 2024; 12(7).

PMID: 39062147 PMC: 11275141. DOI: 10.3390/biomedicines12071574.


Effects of Aerobic Exercise Therapy through Nordic Walking Program in Lactate Concentrations, Fatigue and Quality-of-Life in Patients with Long-COVID Syndrome: A Non-Randomized Parallel Controlled Trial.

Laguarta-Val S, Varillas-Delgado D, Lizcano-Alvarez A, Molero-Sanchez A, Melian-Ortiz A, Cano-de-la-Cuerda R J Clin Med. 2024; 13(4).

PMID: 38398348 PMC: 10889227. DOI: 10.3390/jcm13041035.


Synthesis of multivalent sialyllactose-conjugated PAMAM dendrimers: Binding to SARS-CoV-2 spike protein and influenza hemagglutinin.

He P, Xia K, Song Y, Tandon R, Channappanavar R, Zhang F Int J Biol Macromol. 2023; 246:125714.

PMID: 37423440 PMC: 10528195. DOI: 10.1016/j.ijbiomac.2023.125714.


Pooled Prevalence of Long COVID-19 Symptoms at 12 Months and Above Follow-Up Period: A Systematic Review and Meta-Analysis.

Mudgal S, Gaur R, Rulaniya S, T L, Agarwal R, Kumar S Cureus. 2023; 15(3):e36325.

PMID: 37077615 PMC: 10108372. DOI: 10.7759/cureus.36325.

References
1.
Lund L, Hallas J, Nielsen H, Koch A, Mogensen S, Brun N . Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021; 21(10):1373-1382. PMC: 8110209. DOI: 10.1016/S1473-3099(21)00211-5. View

2.
Seessle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A . Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis. 2021; 74(7):1191-1198. PMC: 8394862. DOI: 10.1093/cid/ciab611. View

3.
Fletcher C, ELMES P, FAIRBAIRN A, Wood C . The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959; 2(5147):257-66. PMC: 1990153. DOI: 10.1136/bmj.2.5147.257. View

4.
Schwartz I, Boesen M, Cerchiaro G, Doram C, Edwards B, Ganesh A . Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial. CMAJ Open. 2021; 9(2):E693-E702. PMC: 8248582. DOI: 10.9778/cmajo.20210069. View

5.
Bansback N, Tsuchiya A, Brazier J, Anis A . Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One. 2012; 7(2):e31115. PMC: 3273479. DOI: 10.1371/journal.pone.0031115. View